Discusses the conflict between increasingly diverse applications of biotechnology in pharmaceutical and agriculture sectors in Asia and the policy challenges that are arising in tandem, concerning trade in GMOs, the impact of genetic engineering on environment and human health, biosafety management, and ethical aspects that are yet to be addressed at any collective forum.